Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain
2 other identifiers
interventional
7
1 country
1
Brief Summary
Research study to determine if putting local anesthetic-or numbing medication-through one or two tiny tube(s) placed next to the nerves that go to an amputated limb will decrease phantom limb and/or stump pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2008
CompletedFirst Posted
Study publicly available on registry
April 28, 2008
CompletedStudy Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJune 28, 2012
June 1, 2012
2.3 years
April 24, 2008
June 26, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary analysis will compare the two treatment groups for the phantom limb/stump pain change from baseline to 4 weeks following the initial catheter placement
Week 4
Secondary Outcomes (3)
Physical Functioning · Brief Pain Inventory
pre-intervention, then days 1, 3, 8, 28, 84, and 365
Nervous System Reorganization [if patient elected to participate in the MRI procedures] · MRI procedure
pre-intervention; and then 8 and 28 days post-intervention
Pain · 11-point numeric rating scale of pain intensity · Usage of baseline and rescue analgesics in previous 24 hours · Patient Global Impression of Change scale
Day 8, Day 28, Month 12
Study Arms (2)
Active
ACTIVE COMPARATOR3-7 days of perineural local anesthetic infusion
Placebo
PLACEBO COMPARATOR3-7 days of perineural normal saline infusion
Interventions
Subjects will be randomized to one of two groups: ropivacaine 0.4% or normal saline (placebo). The basal rate will be set at 7 mL/h.
Eligibility Criteria
You may qualify if:
- previous upper or lower limb amputation including at least one metacarpal or metatarsal bone, respectively
- age 18 years or older
- phantom limb and/or stump pain described as at least a 2 on the NRS for the previous week \[and pain occurring on a weekly basis over the previous month\]
- willing to have an ambulatory perineural infusion for 6 days
- willing to avoid additional "new" analgesic interventions from 4 weeks prior to at least 4 weeks following catheter placement, and preferably to 6 months following catheter placement
- the availability of a "caretaker" who will transport the subject home following the procedure and remain with the subject for the first night of the infusion
You may not qualify if:
- known hepatic or renal insufficiency
- allergy to the study medications
- possessing a contraindication to perineural catheter placement or perineural local anesthetic infusion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Diegolead
- Summit Medicalcollaborator
- National Institute of General Medical Sciences (NIGMS)collaborator
Study Sites (1)
UCSD Medical Center
San Diego, California, 92103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Ilfeld, M.D., M.S.
University of California, San Diego
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, In Residence
Study Record Dates
First Submitted
April 24, 2008
First Posted
April 28, 2008
Study Start
October 1, 2008
Primary Completion
January 1, 2011
Study Completion
December 1, 2011
Last Updated
June 28, 2012
Record last verified: 2012-06